International Biotechnology Trust as of Sept. 30, 2017
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 56 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 10.2 | $26M | 181k | 145.79 | |
Biogen Idec (BIIB) | 8.7 | $22M | 72k | 312.93 | |
Regeneron Pharmaceuticals (REGN) | 7.1 | $18M | 41k | 447.05 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $14M | 89k | 152.03 | |
Alexion Pharmaceuticals | 5.0 | $13M | 92k | 140.28 | |
Incyte Corporation (INCY) | 4.0 | $10M | 89k | 116.73 | |
Gilead Sciences (GILD) | 3.9 | $9.9M | 123k | 81.00 | |
ACADIA Pharmaceuticals (ACAD) | 3.5 | $9.1M | 241k | 37.66 | |
Adamas Pharmaceuticals | 3.2 | $8.3M | 390k | 21.16 | |
Amgen (AMGN) | 2.6 | $6.7M | 36k | 186.32 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $6.4M | 68k | 93.03 | |
Entellus Medical Cm | 2.5 | $6.3M | 342k | 18.46 | |
Exelixis (EXEL) | 2.4 | $6.2M | 254k | 24.23 | |
Acceleron Pharma | 2.2 | $5.7M | 154k | 37.42 | |
Sarepta Therapeutics (SRPT) | 2.1 | $5.5M | 121k | 45.36 | |
Paratek Pharmaceuticals | 2.0 | $5.1M | 202k | 25.10 | |
Halozyme Therapeutics (HALO) | 1.9 | $4.9M | 283k | 17.36 | |
Alnylam Pharmaceuticals (ALNY) | 1.9 | $4.8M | 41k | 117.43 | |
Clovis Oncology | 1.8 | $4.6M | 56k | 82.39 | |
Tesaro | 1.8 | $4.5M | 35k | 129.09 | |
Sangamo Biosciences (SGMO) | 1.6 | $4.1M | 273k | 15.00 | |
Neurocrine Biosciences (NBIX) | 1.6 | $4.0M | 66k | 61.27 | |
Ligand Pharmaceuticals In (LGND) | 1.5 | $3.9M | 29k | 136.07 | |
Five Prime Therapeutics | 1.4 | $3.5M | 87k | 40.87 | |
Seattle Genetics | 1.2 | $3.1M | 58k | 54.42 | |
Array BioPharma | 1.2 | $3.0M | 248k | 12.30 | |
Calithera Biosciences | 1.1 | $3.0M | 188k | 15.70 | |
Dermira | 1.1 | $2.9M | 108k | 27.00 | |
Juno Therapeutics | 1.1 | $2.8M | 63k | 44.83 | |
Synergy Pharmaceuticals | 1.1 | $2.8M | 972k | 2.88 | |
Bluebird Bio (BLUE) | 1.1 | $2.7M | 20k | 137.30 | |
Ionis Pharmaceuticals (IONS) | 1.0 | $2.6M | 52k | 50.70 | |
Kalvista Pharmaceuticals (KALV) | 0.8 | $2.1M | 322k | 6.66 | |
D Stemline Therapeutics | 0.8 | $2.0M | 183k | 11.10 | |
Fibrogen (FGEN) | 0.7 | $1.7M | 31k | 53.76 | |
Avexis | 0.6 | $1.6M | 17k | 96.71 | |
Corcept Therapeutics Incorporated (CORT) | 0.6 | $1.6M | 83k | 19.29 | |
Veracyte (VCYT) | 0.6 | $1.5M | 170k | 8.76 | |
Agios Pharmaceuticals (AGIO) | 0.5 | $1.3M | 20k | 66.70 | |
Omeros Corporation (OMER) | 0.5 | $1.3M | 61k | 21.62 | |
Portola Pharmaceuticals | 0.5 | $1.3M | 24k | 54.04 | |
Transenterix | 0.5 | $1.3M | 889k | 1.43 | |
Achaogen | 0.5 | $1.2M | 75k | 15.95 | |
Spark Therapeutics | 0.4 | $1.1M | 12k | 89.08 | |
Sage Therapeutics (SAGE) | 0.4 | $1.1M | 17k | 62.31 | |
G1 Therapeutics (GTHX) | 0.4 | $971k | 39k | 24.90 | |
Ironwood Pharmaceuticals (IRWD) | 0.4 | $930k | 59k | 15.76 | |
Amicus Therapeutics (FOLD) | 0.3 | $883k | 59k | 15.07 | |
Horizon Pharma | 0.3 | $876k | 69k | 12.70 | |
Supernus Pharmaceuticals (SUPN) | 0.3 | $838k | 21k | 39.99 | |
Aerie Pharmaceuticals | 0.3 | $718k | 15k | 48.58 | |
Radius Health | 0.3 | $725k | 19k | 38.57 | |
Deciphera Pharmaceuticals (DCPH) | 0.2 | $478k | 25k | 19.12 | |
Xencor (XNCR) | 0.2 | $413k | 18k | 22.94 | |
Molecular Templates | 0.1 | $334k | 48k | 6.94 | |
Assembly Biosciences | 0.1 | $178k | 5.1k | 34.87 |